Maia Biotechnology Stock Price Prediction

MAIA Stock  USD 2.08  0.07  3.26%   
At this time, The RSI of MAIA Biotechnology's share price is at 53. This indicates that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling MAIA Biotechnology, making its price go up or down.

Oversold Vs Overbought

53

 
Oversold
 
Overbought
The successful prediction of MAIA Biotechnology's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with MAIA Biotechnology, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting MAIA Biotechnology's stock price prediction:
EPS Estimate Current Year
(1.30)
EPS Estimate Next Year
(1.35)
Wall Street Target Price
12.625
Using MAIA Biotechnology hype-based prediction, you can estimate the value of MAIA Biotechnology from the perspective of MAIA Biotechnology response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in MAIA Biotechnology to buy its stock at a price that has no basis in reality. In that case, they are not buying MAIA because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

MAIA Biotechnology after-hype prediction price

    
  USD 2.15  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out MAIA Biotechnology Basic Forecasting Models to cross-verify your projections.
For information on how to trade MAIA Stock refer to our How to Trade MAIA Stock guide.
Intrinsic
Valuation
LowRealHigh
0.102.087.24
Details
Naive
Forecast
LowNextHigh
0.041.877.02
Details
1 Analysts
Consensus
LowTargetHigh
10.6911.7513.04
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.33-0.33-0.33
Details

MAIA Biotechnology After-Hype Price Prediction Density Analysis

As far as predicting the price of MAIA Biotechnology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in MAIA Biotechnology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of MAIA Biotechnology, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

MAIA Biotechnology Estimiated After-Hype Price Volatility

In the context of predicting MAIA Biotechnology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on MAIA Biotechnology's historical news coverage. MAIA Biotechnology's after-hype downside and upside margins for the prediction period are 0.11 and 7.31, respectively. We have considered MAIA Biotechnology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
2.08
2.15
After-hype Price
7.31
Upside
MAIA Biotechnology is dangerous at this time. Analysis and calculation of next after-hype price of MAIA Biotechnology is based on 3 months time horizon.

MAIA Biotechnology Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as MAIA Biotechnology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading MAIA Biotechnology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with MAIA Biotechnology, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.39 
5.17
  0.02 
  0.08 
8 Events / Month
9 Events / Month
In about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
2.08
2.15
0.00 
10,340  
Notes

MAIA Biotechnology Hype Timeline

MAIA Biotechnology is now traded for 2.08. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of -0.08. MAIA is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at -0.39%. %. The volatility of related hype on MAIA Biotechnology is about 2524.88%, with the expected price after the next announcement by competition of 2.00. About 17.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 1.34. MAIA Biotechnology had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days.
Check out MAIA Biotechnology Basic Forecasting Models to cross-verify your projections.
For information on how to trade MAIA Stock refer to our How to Trade MAIA Stock guide.

MAIA Biotechnology Related Hype Analysis

Having access to credible news sources related to MAIA Biotechnology's direct competition is more important than ever and may enhance your ability to predict MAIA Biotechnology's future price movements. Getting to know how MAIA Biotechnology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how MAIA Biotechnology may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
LCTXLineage Cell Therapeutics 0.01 5 per month 0.00 (0.12) 6.98 (5.32) 39.60 
ARMPArmata Pharmaceuticals(0.23)4 per month 0.00 (0.03) 6.19 (7.05) 33.83 
FREQFrequency Therapeutics(0.02)2 per month 3.90  0.06  5.71 (6.15) 90.18 
PRTGPortage Biotech(0.03)2 per month 9.06  0.10  15.56 (14.59) 154.25 
AGEAgeX Therapeutics 0.00 0 per month 4.99  0.07  8.20 (9.20) 47.55 
LRMRLarimar Therapeutics(0.49)9 per month 0.00 (0.07) 10.87 (9.55) 26.71 
GRPHGraphite Bio(0.03)1 per month 0.00 (0.07) 4.79 (4.73) 14.40 
LYRALyra Therapeutics 0.01 5 per month 0.00 (0.13) 8.00 (10.00) 41.07 
GNLXGenelux Common(0.07)7 per month 5.21  0.06  13.94 (8.61) 40.11 
CMRAComera Life Sciences 0.00 0 per month 0.00 (0.01) 13.95 (12.70) 30.28 
DYAIDyadic International 0.09 6 per month 3.72  0.07  8.57 (7.20) 16.89 
CINGCingulate(0.36)5 per month 0.00 (0.14) 9.27 (11.28) 38.00 
MNPRMonopar Therapeutics(2.62)9 per month 7.94  0.13  15.93 (9.50) 653.56 
TRGNFTransgene SA 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
EPRXFEupraxia Pharmaceuticals 0.00 0 per month 0.00 (0.15) 5.76 (6.17) 36.58 
CSBRChampions Oncology(0.24)6 per month 3.87 (0.02) 6.23 (6.96) 22.49 
LUMOLumos Pharma(0.13)5 per month 2.62  0.13  6.35 (5.19) 26.13 
ROIVWRoivant Sciences(0.21)2 per month 4.20  0.11  8.80 (7.03) 24.42 
FTHWFField Trip Health 0.00 0 per month 0.00 (0.12) 0.00 (7.50) 30.40 
TLPPFTelix Pharmaceuticals Limited 0.00 0 per month 3.74  0.01  5.78 (5.49) 18.38 
NAUTNautilus Biotechnology 0.02 6 per month 3.63 (0.02) 6.23 (6.50) 17.75 

MAIA Biotechnology Additional Predictive Modules

Most predictive techniques to examine MAIA price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for MAIA using various technical indicators. When you analyze MAIA charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About MAIA Biotechnology Predictive Indicators

The successful prediction of MAIA Biotechnology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as MAIA Biotechnology, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of MAIA Biotechnology based on analysis of MAIA Biotechnology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to MAIA Biotechnology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to MAIA Biotechnology's related companies.

Story Coverage note for MAIA Biotechnology

The number of cover stories for MAIA Biotechnology depends on current market conditions and MAIA Biotechnology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that MAIA Biotechnology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about MAIA Biotechnology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

MAIA Biotechnology Short Properties

MAIA Biotechnology's future price predictability will typically decrease when MAIA Biotechnology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of MAIA Biotechnology often depends not only on the future outlook of the potential MAIA Biotechnology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MAIA Biotechnology's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding13.3 M
Cash And Short Term Investments7.2 M
Shares Float19.5 M

Complementary Tools for MAIA Stock analysis

When running MAIA Biotechnology's price analysis, check to measure MAIA Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MAIA Biotechnology is operating at the current time. Most of MAIA Biotechnology's value examination focuses on studying past and present price action to predict the probability of MAIA Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MAIA Biotechnology's price. Additionally, you may evaluate how the addition of MAIA Biotechnology to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Transaction History
View history of all your transactions and understand their impact on performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges